Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1461

1.

Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.

Masuko T, Namiki R, Nemoto Y, Miyake M, Kizawa Y, Suzuki T, Kashiwagi K, Igarashi K, Kusama T.

J Pharmacol Exp Ther. 2009 Nov;331(2):522-30. doi: 10.1124/jpet.109.152926. Epub 2009 Jul 30.

2.

Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.

Masuko T, Suzuki T, Miyake M, Kusama-Eguchi K, Kizawa Y, Tomono K, Kashiwagi K, Igarashi K, Kusama T.

Neurosci Lett. 2012 Jan 11;506(2):251-5. doi: 10.1016/j.neulet.2011.11.017. Epub 2011 Nov 20.

PMID:
22119002
3.

Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors.

Masuko T, Nemoto Y, Nagaoka H, Miyake M, Kizawa Y, Kusama-Eguchi K, Kashiwagi K, Igarashi K, Kusama T.

Neuropharmacology. 2007 Sep;53(4):515-23. Epub 2007 Jun 29.

PMID:
17681353
4.

Differential effects of linear and cyclic polyamines on NMDA receptor activities.

Masuko T, Miyake M, Kusama-Eguchi K, Koike T, Kimura E, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T.

Neurochem Int. 2008 Jul;53(1-2):38-44. doi: 10.1016/j.neuint.2008.04.009. Epub 2008 May 8.

PMID:
18556092
5.
6.

N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.

Chao J, Seiler N, Renault J, Kashiwagi K, Masuko T, Igarashi K, Williams K.

Mol Pharmacol. 1997 May;51(5):861-71.

7.

Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.

Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T.

Neurochem Int. 2007 Jan;50(2):443-9. Epub 2006 Nov 17.

PMID:
17113196
8.

Imidazoline-induced neuroprotective effects result from blockade of NMDA receptor channels in neuronal cultures.

Milhaud D, Fagni L, Bockaert J, Lafon-Cazal M.

Neuropharmacology. 2000 Sep;39(12):2244-54.

PMID:
10974308
11.

Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.

Igarashi K, Shirahata A, Pahk AJ, Kashiwagi K, Williams K.

J Pharmacol Exp Ther. 1997 Nov;283(2):533-40.

12.

Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.

Kashiwagi K, Tanaka I, Tamura M, Sugiyama H, Okawara T, Otsuka M, Sabado TN, Williams K, Igarashi K.

J Pharmacol Exp Ther. 2004 Jun;309(3):884-93. Epub 2004 Feb 5.

14.

Synthesis of water-soluble polyamine derivatives effective as N-methyl-D-aspartate receptor antagonists.

Masuko T, Yoshida S, Metori K, Kizawa Y, Kusama T, Miyake M.

Chem Pharm Bull (Tokyo). 2010 Jun;58(6):862-7.

15.

Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.

Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.

Mol Pharmacol. 1996 Dec;50(6):1541-50.

PMID:
8967976
16.
17.

Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.

Igarashi K, Williams K.

J Pharmacol Exp Ther. 1995 Mar;272(3):1101-9.

PMID:
7891322
19.

Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity.

Akasofu S, Kimura M, Kosasa T, Ogura H, Sawada K.

Eur J Pharmacol. 2006 Jan 20;530(3):215-22.

PMID:
16406045
20.

Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.

Williams K, Dattilo M, Sabado TN, Kashiwagi K, Igarashi K.

J Pharmacol Exp Ther. 2003 May;305(2):740-8. Epub 2003 Feb 11.

Supplemental Content

Support Center